March 30, 2026

Pregnancy-Linked SCAD More Severe

Data presented at the American College of Cardiology 75th Annual Scientific Session linked pregnancy-associated SCAD to more severe presentation and higher in-hospital major adverse cardiovascular events.

Conexiant

March 30, 2026

Side Effects: Variety Is Overrated

The organ you forgot, the cells that age unevenly, the AI that admits ignorance, and the diet advice that sounds wrong but isn't: medicine's next moves are hiding in plain sight.

Conexiant

March 26, 2026

FDA Clears AI Guidance Tool for Mitral Repair

AI enhances real-time intraprocedural visualization and navigation.

Conexiant

March 24, 2026

Suspended Lead Suits Linked to Lower Radiation in LAAO

Study shows suspended lead suits reduce head-level radiation exposure during left atrial appendage occlusion procedures

Conexiant

March 04, 2026

Low-Dose Rivaroxaban Did Not Reduce LV Thrombus After Anterior STEMI

Adding low-dose rivaroxaban to dual antiplatelet therapy following anterior myocardial infarction did not reduce cardiac MRI–detected left ventricular thrombus at 1 month and increased minor bleeding in a 560-patient randomized trial.

Conexiant

November 14, 2024

AI-Powered Camera Detects Hypertension, Diabetes

An AI-powered high-speed video camera offers quick, no-contact screenings for high blood pressure and diabetes by analyzing blood flow features in face and palm skin, achieving impressive accuracies.

Reuters

November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

January 09, 2025

Study: Aspirin Shields SLE Patients from ASCVD

A recent study has linked antiphospholipid antibodies to atherosclerotic cardiovascular disease in systemic lupus erythematosus patients, highlighting the potential of aspirin to reduce risk. Source: BMC Medicine

Conexiant

April 30, 2025

ApoB Count and Lp(a) Levels Key to CAD Risk

Total apoB particle count and Lp(a) levels best reflect coronary artery disease risk, with researchers noting that lipid-related atherosclerotic risk is most accurately reflected by the total count of apoB-P.

Conexiant

May 30, 2025

Mepolizumab Reduces COPD Flares in Eosinophilic Patients

A new clinical trial found that adding mepolizumab to standard inhaled therapy significantly reduced moderate or severe COPD exacerbations in patients with high eosinophil counts, with a 21% lower annual rate and longer time to first flare.

Conexiant